Core Viewpoint - The company has announced a delay in the expected operational status of two fundraising investment projects, extending the timeline for the "Jixi Branch Phase III Project" to August 2026 and the "Traditional Chinese Medicine Material Processing Project" to October 2026 [1][4][10] Fundraising Overview - The company raised a total of RMB 1,237,999,917.28 through a non-public offering of 92,803,592 shares at a price of RMB 13.34 per share, with a net amount of RMB 1,217,240,132.22 after deducting issuance costs [1][2] - The funds are stored in a dedicated account, and a three-party/four-party supervision agreement has been signed [1] Investment Project Details - The company has made adjustments to its fundraising investment projects due to changes in market conditions and policy adjustments, including the termination of certain sub-projects and reallocating funds to other projects [2][3] - The "Jixi Branch Phase III Project" involves the construction of a chemical synthesis workshop and related facilities, with construction progress affected by industry policies and competition [8] Delay Reasons and Measures - The delays in project timelines are attributed to construction progress lagging behind the original schedule, necessitating a cautious review and adjustment of the expected operational status [6][9] - The company plans to implement measures to ensure compliance and efficient use of the raised funds, including strict supervision of project progress [9] Approval Process - The delay in the investment projects was approved by the company's board of directors, following necessary procedures and compliance with relevant regulations [10]

Group 1 - The company Zhejiang Huaye Plastic Machinery Co., Ltd. has postponed the investment projects funded by its initial public offering (IPO) due to various factors including the late arrival of funds and changes in project locations [1][4]. - The total amount raised from the IPO was RMB 417.4 million, with a net amount of RMB 356.32 million after deducting issuance costs [1][2]. - The company has signed a regulatory agreement with the commercial bank managing the raised funds to ensure proper oversight [2]. Group 2 - The adjusted investment plan includes a total investment of RMB 672 million, with the net amount from the IPO allocated to specific projects [3]. - The postponement of the investment projects does not involve changes to the project content, implementation methods, or investment amounts, ensuring that shareholder interests are maintained [4][5]. - The board of directors and the supervisory board have approved the postponement, confirming that all necessary procedures have been followed [5].

兴业证券股份有限公司 关于福建海峡环保集团股份有限公司 部分募集资金投资项目延期的核查意见 兴业证券股份有限公司（以下简称"兴业证券"或"保荐机构"）作为福建 海峡环保集团股份有限公司（以下简称"海峡环保"）2022 年非公开发行股票 的保荐机构，根据《证券发行上市保荐业务管理办法》、《上市公司监管指引第 市规则》及《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等法 律法规及规范性文件的规定，对海峡环保 2022 年非公开发行股票部分募集资金 投资项目（以下简称"募投项目"）延期事项进行了核查，核查情况如下： 一、募集资金基本情况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于核准福建海 峡环保集团股份有限公司非公开发行股票的批复》（证监许可〔2022〕501 号） 核准，海峡环保非公开发行股票 84,158,415 股，每股发行价格人民币 6.06 元。 募集资金总额为人民币 50,999.99949 万元，扣除发行费用（不含增值税）人民币 的 XYZH/2022XMAA10155 号《非公开发行股票募集资金验资报告》验证。海 峡环保开立了募集资金专户，募集资金已全部存放于经董事会批 ...

Group 1 - The core point of the announcement is the approval of the extension of a fundraising investment project without changing the total investment amount or the purpose of the funds [1][2] - The project in question is the construction of a special polymer material production facility with an annual capacity of 45,000 tons [1] - The decision was made during the seventh meeting of the fifth supervisory board, which was held on August 1, 2025, with all three supervisors present [1][2] Group 2 - The vote on the extension proposal resulted in 3 votes in favor, with no votes against or abstentions [2] - The company assures that the extension does not negatively impact the implementation of the fundraising project or the interests of shareholders [1] - The announcement also complies with relevant regulations from the China Securities Regulatory Commission and the Shenzhen Stock Exchange regarding the management of raised funds [1]

Group 1 - The company held its fifth board meeting on August 1, 2025, with all seven directors present, and the meeting was chaired by the chairman Wu Xian [1][2] - The board approved the proposal to postpone the fundraising project for the annual production of 45,000 tons of special polymer materials, which will not affect the company's current operations or shareholder interests [2][3] - The board also approved amendments to the company's articles of association to enhance governance structure and operational standards, which will be submitted for shareholder approval [3][4] Group 2 - The company revised and established several governance systems to promote standardized operations and improve internal management mechanisms, with unanimous approval from the board [4][5] - A three-year shareholder return plan for 2025-2027 was approved to establish a scientific and stable return mechanism for shareholders, which will also require shareholder approval [5][6] - The board agreed not to hold a shareholder meeting immediately after this board meeting, with plans to notify shareholders later regarding the meeting [5][6]

经中国证监会《关于核准海南珠江控股股份有限公司向北京粮食集团有限责任公司 等发行股份购买资产并募集配套资金的批复》（证监许可〔2017〕1391 号）核准，同 意公司非公开发行不超过 48,965,408 股新股，发行价 8.82 元/股，募集配套资金总额不 超过人民币 43,187.49 万元。京粮控股实际募集资金总额为人民币 431,874,898.56 元， 扣除发行费用人民币 45,000,000.00 元，募集资金净额为人民币 386,874,898.56 元。上述 募集资金已全部到位，并由中兴华会计师事务所（特殊普通合伙）于 2017 年 10 月 16 日出具的《验资报告》（中兴华验字(2017) 第 010120 号）审验确认。京粮控股对募集 资金实行专户存储，并与独立财务顾问、募集资金开户行签署了募集资金三方监管协议。 东兴证券股份有限公司 关于海南京粮控股股份有限公司 募集资金投资项目延期的核查意见 京粮控股于 2023 年 11 月 21 日分别召开了第十届董事会第九次会议和第十届监事 会第八次会议，并于 2023 年 12 月 8 日召开了 2023 年第二次临时股东大会，审议通过 了 ...

Core Viewpoint - The company, Shanghai Annuoqi Group Co., Ltd., has decided to postpone the expected usable status date for its "Yantai Annual Production of 30,000 Tons of Dye Intermediate Production Project" from July 31, 2025, to December 31, 2025, due to the current progress of the project and the need for additional time for completion and verification [5][6][7]. Fundraising Overview - The company raised a total of RMB 419,040,000 by issuing 72,000,000 shares at a price of RMB 5.82 per share in November 2017, with a net amount of RMB 405,173,962.27 after deducting issuance costs [1]. - The funds are managed under a strict system to ensure they are used for their intended purposes, with agreements in place for supervision [2]. Fund Usage Status - The total investment for the "Yantai Annual Production of 30,000 Tons of Dye Intermediate Production Project" is RMB 70,000,000, with RMB 29,738,470 already invested as of the latest report [2][3]. - The project has reached a production capacity of 16,177 tons of disperse dye intermediates, stabilizing the company's raw material supply [6]. Project Delay Details - The delay in the project is primarily due to the need for additional time to complete the verification process and ensure high-quality implementation [6][7]. - The company has confirmed that the basic content of the project remains unchanged, and the delay will not affect the intended use of the funds or harm shareholder interests [5][7]. Approval Process - The decision to postpone the project has been approved by the company's board of directors and supervisory board, ensuring compliance with relevant regulations [7]. Sponsor's Verification Opinion - The sponsor, Guotai Junan Securities Co., Ltd., has verified that the postponement of the fundraising project complies with relevant regulations and will not materially affect the project's implementation [7].

Core Points - Zhejiang Huahai Pharmaceutical Co., Ltd. has announced a delay in the "Formulation Digital Intelligent Manufacturing Construction Project" to December 2026, as approved by the board of directors on July 24, 2025 [1][4] - The delay only involves adjustments to the project timeline and does not change the use of raised funds or negatively impact the company's normal operations or shareholder interests [1][4][5] - The total amount raised from the issuance of shares was approximately CNY 600 million, with a net amount of approximately CNY 582 million after deducting issuance costs [1][2] Fundraising Overview - The company raised CNY 599,999,994.54 by issuing 41,152,263 shares at a price of CNY 14.58 per share, with net proceeds of CNY 582,319,365.51 after deducting issuance costs [1][2] - The funds are allocated to two main projects: the "Formulation Digital Intelligent Manufacturing Construction Project" and working capital, with total planned investments of CNY 172,274.12 million [2] Project Delay Details - The original completion date for the "Formulation Digital Intelligent Manufacturing Construction Project" was set for July 2025, now postponed to December 2026 due to the project's large scale and external factors [3] - The project aims to integrate various information systems to create a fully automated production line with a designed capacity of 15 billion tablets per year [3] Impact of Delay - The delay is a strategic decision based on objective project conditions and will not materially affect the implementation of the project or the company's operations [4][5] - The company emphasizes that the delay does not involve changes to the investment content, purpose, total amount, or implementation entity of the project [4][5] Approval Process - The delay was approved through a series of meetings, including the board of directors and independent directors, and does not require shareholder approval [4][5][6]

Summary of Key Points Core Viewpoint - The company, Shenzhen Minglida Precision Technology Co., Ltd., has decided to postpone certain fundraising investment projects due to market changes and operational needs, reallocating part of the raised funds to a new project in Mexico [1][10]. Group 1: Fundraising Overview - The company issued 10 million convertible bonds with a total face value of 1 billion yuan, netting approximately 991.61 million yuan after deducting issuance costs [1]. - The funds are managed in a dedicated account with strict regulatory oversight, ensuring compliance with relevant laws and regulations [5][11]. Group 2: Investment Projects - The original investment projects included the construction of precision component production bases in Anhui and Jiangxi, and a smart manufacturing project for key components [3]. - The company plans to redirect 45 million yuan (45% of total raised funds) from the postponed projects to a new project for constructing a precision component production base for electric vehicles in Mexico [4][10]. Group 3: Project Postponement Details - The project for the Jiangxi precision component production base will experience delays in reaching its operational status due to various market and operational factors [9][10]. - The postponement does not alter the investment amounts or project content, ensuring no adverse impact on shareholder interests [10][12]. Group 4: Compliance and Oversight - The company has followed necessary procedures for the project postponement, receiving approval from both the board of directors and the supervisory board [11][12]. - The sponsor, Guotai Junan Securities, has confirmed that the postponement complies with regulatory requirements and does not harm the company's or shareholders' interests [12].

Group 1 - The company held a meeting on July 18, 2025, with all three supervisors present, and the meeting was convened in accordance with relevant laws and regulations [1][2] - The meeting approved a proposal to postpone certain fundraising investment projects, which the supervisory board deemed a prudent decision based on the company's development and current circumstances [1][2] - The decision aligns with the regulations set forth in the "Regulations on the Supervision of Fundraising by Listed Companies" and other relevant guidelines [1]